Prelude Capital Management’s Oramed Pharmaceuticals ORMP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-13,435
Closed -$28.8K 1220
2025
Q1
$28.8K Sell
13,435
-300
-2% -$642 ﹤0.01% 1030
2024
Q4
$33.2K Sell
13,735
-700
-5% -$1.69K ﹤0.01% 1033
2024
Q3
$35.2K Buy
+14,435
New +$35.2K ﹤0.01% 1121